Word: profits
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Thompson, 62, certainly miscalculated. A bookkeeper for an electrical contractor, she retired in May 2000 mainly on the security of $300,000 in a company profit-sharing plan. But the bear market has claimed half of her retirement pie, and Thompson, a divorce, recently gave up hope of finding a job in her hometown of Chesterfield, Mo. She will start looking again in the fall, she says. Her money had been invested in a mix of bonds, tech stocks, blue chips and large-company growth funds. She's kicking herself for not investing more conservatively...
...Toulouse, France, Airbus is jointly owned by two private aerospace companies, European Aeronautic Defense & Space Co. and BAE Systems, but is receiving subsidies from European governments in the form of $3 billion in loans that don't have to be repaid if the A380 fails to turn a profit. Boeing gets indirect handouts through its lucrative defense contracts, but critics say they aren't sufficient to level the playing field, and U.S. officials occasionally threaten to punish Airbus. The political equation may be changing, though. "U.S. companies are thrilled to be a part of the A380," says Mark Sullivan...
Twenty years ago, when most current undergraduates were still spitting up their mother’s milk (then still-uncontaminated by transgenic proteins) the relationship of the University to for-profit biotechnology companies was the subject of somber faculty meetings and cautious pronouncements by former University President Derek C. Bok. Although the relationship between the faculty and the biotech industry is less strained than it once was, the problems of actually building companies has not gone away—and those problems illustrate why Summers’ comparison to the electronics industry that grew up around Stanford University...
...biotech industry in California, has seen collaborations with companies for research drop by nearly half from 2000. Such stark figures should give Summers pause before he starts intertwining Harvard research with the work of biotech companies. Indeed, Harvard has always been hesitant to associate itself too closely with for-profit companies. Cambridge-based Vertex Phamaceuticals, which includes former Dean of the Faculty of Arts and Sciences Jeremy R. Knowles on its scientific advisory board, tried to name itself “Veritas” when it was founded in 1989. Knowles, however, interceded and convinced the company...
...much slower than with easy-to-manufacture microchips. Products such as drugs take decades to pass through strict government reviews. Europeans refuse to eat genetically engineered food. Biotechnology is less of a Silicon Valley-style gold rush than a minefield where only the truly exceptional companies can turn a profit before they burn through all their capital...